Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian O Ellis

Showing results (1-10 of 430) with videos related to

Pageof 43
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 4, 2010
Intraductal proliferative lesions of the breast: morphology, associated risk and molecular biologyIan O Ellis
Breast Cancer Research : BCR|August 21, 2003
The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classificationSarah E Pinder, Ian O Ellis
Histopathology|September 17, 2013
Authors' reply: Combining two antibodies to define E-cadherin loss of expression in non-lobular breast carcinomas: when less is moreEmad A Rakha, Ian O Ellis
Nature Reviews. Clinical Oncology|December 11, 2013
Breast cancer: updated guideline recommendations for HER2 testingEmad A Rakha, Ian O Ellis
Seminars in Diagnostic Pathology|March 24, 2010
Lobular breast carcinoma and its variantsEmad A Rakha, Ian O Ellis
Advances in Anatomic Pathology|June 10, 2011
Modern classification of breast cancer: should we stick with morphology or convert to molecular profile characteristicsEmad A Rakha, Ian O Ellis
Pathology|November 29, 2017
Diagnostic challenges in papillary lesions of the breastEmad A Rakha, Ian O Ellis
Pathology|December 18, 2008
Triple-negative/basal-like breast cancer: reviewEmad A Rakha, Ian O Ellis
Journal of Clinical Pathology|March 28, 2013
Myoepithelial and epithelial-myoepithelial, mesenchymal and fibroepithelial breast lesions: updates from the WHO Classification of Tumours of the Breast 2012Puay Hoon Tan, Ian O Ellis
Virchows Archiv : an International Journal of Pathology|June 14, 2022
The frequency of HER2 amplification and the percentage of membrane staining in HER2 2 + invasive carcinomas of the breastAndrew H S Lee, Ian O Ellis
Pageof 43

Showing results (1-10 of 430) with videos related to

Sort By:
Pageof 43
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 4, 2010
Intraductal proliferative lesions of the breast: morphology, associated risk and molecular biologyIan O Ellis
Breast Cancer Research : BCR|August 21, 2003
The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classificationSarah E Pinder, Ian O Ellis
Histopathology|September 17, 2013
Authors' reply: Combining two antibodies to define E-cadherin loss of expression in non-lobular breast carcinomas: when less is moreEmad A Rakha, Ian O Ellis
Nature Reviews. Clinical Oncology|December 11, 2013
Breast cancer: updated guideline recommendations for HER2 testingEmad A Rakha, Ian O Ellis
Seminars in Diagnostic Pathology|March 24, 2010
Lobular breast carcinoma and its variantsEmad A Rakha, Ian O Ellis
Advances in Anatomic Pathology|June 10, 2011
Modern classification of breast cancer: should we stick with morphology or convert to molecular profile characteristicsEmad A Rakha, Ian O Ellis
Pathology|November 29, 2017
Diagnostic challenges in papillary lesions of the breastEmad A Rakha, Ian O Ellis
Pathology|December 18, 2008
Triple-negative/basal-like breast cancer: reviewEmad A Rakha, Ian O Ellis
Journal of Clinical Pathology|March 28, 2013
Myoepithelial and epithelial-myoepithelial, mesenchymal and fibroepithelial breast lesions: updates from the WHO Classification of Tumours of the Breast 2012Puay Hoon Tan, Ian O Ellis
Virchows Archiv : an International Journal of Pathology|June 14, 2022
The frequency of HER2 amplification and the percentage of membrane staining in HER2 2 + invasive carcinomas of the breastAndrew H S Lee, Ian O Ellis
Pageof 43